tulathromycin powder
masteam bio-tech co., ltd. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - tulathromycin 1 kg in 1 kg
tulathromycin a powder
attix pharmaceuticals - tulathromycin a (unii: 897a3kn7ap) (tulathromycin - unii:q839i13422) - tulathromycin a 1 kg in 1 kg
x tulathromycin powder
ax pharmaceutical corp - tulathromycin a (unii: 897a3kn7ap) (tulathromycin a - unii:897a3kn7ap) - tulathromycin a 495 g in 500 g
x- tulathromycin a powder
ax pharmaceutical corp - tulathromycin a (unii: 897a3kn7ap) (tulathromycin a - unii:897a3kn7ap) - tulathromycin a 485 g in 500 g
draxxin 25- tulathromycin injection
zoetis inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - tulathromycin 25 mg in 1 ml - swine draxxin 25 injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae , pasteurella multocida , bordetella bronchiseptica , haemophilus parasuis , and mycoplasma hyopneumoniae ; and for the control of srd associated with actinobacillus pleuropneumoniae , pasteurella multocida , and mycoplasma hyopneumoniae in groups of pigs where srd has been diagnosed. suckling calves, dairy calves, and veal calves brd - draxxin 25 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis . the use of draxxin 25 injectable solution is contraindicated in animals previously found to be hypersensitive to the drug.
draxxin- tulathromycin injection, solution
zoetis inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - tulathromycin 100 mg in 1 ml - brd – draxxin injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis ; and for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis . ibk – draxxin injectable solution is indicated for the treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis . foot rot – draxxin injectable solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum and porphyromonas levii . brd – draxxin injectable solution is indicated for the treatment of brd associated with m. haemolytica, p. multocida, h. somni, and m. bovis. draxxin injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoni
tulathromycin powder
american pharmaceutical ingredients llc - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) -
tulathromycin
zoetis australia pty ltd - tulathromycin - unknown - tulathromycin antibiotic active 0.0 - active constituent
tulathromycin
abbey laboratories pty ltd - tulathromycin - unknown - tulathromycin antibiotic active 0.0 - active constituent
tulathromycin
zoetis australia pty ltd - tulathromycin - unknown - tulathromycin antibiotic active 0.0 - active constituent